Archive for Tag: Pfizer COVID-19 vaccine

Pfizer Stock Price

Pfizer on track for U.S. vaccine boosters, Moderna lagging, Fauci says

Pfizer (NYSE:PFE) is trading flat at 46.84 Top U.S. infectious disease expert Rd. Anthony Fauci said on Sunday that officials were likely to soon get the regulatory go-ahead to administer COVID-19 vaccine booster shots made byPfizer(NYSE:PFE), althoughModerna(NASDAQ:MRNA) booster could take a little longer. Asked on CBS’ “Face the Nation,”...

Read More
Best Stock To Buy Now

Top 5 Stocks To Watchout & Trade Today – July 12, 2021

1. PFIZER: COVID-19 vaccine maker Pfizer Inc (NYSE: PFE) will meet with federal health officials as soon as Monday to discuss the need for a booster dose of the coronavirus vaccine as it prepares to seek authorization, the company said on Sunday. The meeting comes days after the drugmaker and...

Read More
Best Stock To Buy Now

Top 5 Stocks To Watchout & Trade Today – July 09, 2021

1. PFIZER:Pfizer Inc plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, the drugmaker’s top scientist said on Thursday, based on evidence of greater risk of reinfection six months after inoculation and the spread of the highly contagious Delta variant....

Read More
Johnson & Johnson

J&J vaccine drive stalls out in U.S after safety pause

Johnson & Johnson (NYSE:JNJ) is trading down 0.04% at 165.97 Safety concerns about Johnson & Johnson (NYSE:JNJ)’s COVID-19 vaccine along with overall flagging demand for vaccinations have slowed its U.S. rollout to a crawl, leaving close to half of the 21 million doses produced for the United States sitting...

Read More

UK competition regulator looking into $39 billion AstraZeneca-Alexion deal

AstraZeneca (NASDAQ:AZN) is trading down 0.26% at 8129.00 Britain’s competition regulator is reviewing AstraZeneca (NASDAQ:AZN)’s $39 billion buyout of U.S.-based Alexion (NASDAQ:ALXN) on concerns it could reduce competition in the UK market or elsewhere. The UK’s Competition and Markets Authority (CMA) said on Tuesday it was inviting comments from...

Read More

BioNTech to build mRNA vaccine manufacturing site in Singapore

BioNTech plans to set up a regional centre and a new factory in Singapore for its vaccines, it said on Monday, boosting its presence in Asia as a debate over patents rages and pressure grows on drugmakers to raise output of COVID-19 shots. Governments are looking to build up...

Read More

Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion

Pfizer (NYSE:PFE) DOWN 1.52% AT 5238.20 Pfizer Inc on Tuesday forecast $26 billion in sales of the COVID-19 vaccine this year, an increase of more than 70% from its last projection and a reflection of the growing global vaccination drive. The vaccine, which it co-developed with Germany’s BioNTech SE...

Read More
Pfizer COVID

Israel examining heart inflammation cases in people who received Pfizer COVID shot

Pfizer (NYSE:PFE) UP 0.05% AT 38.66 Israel’s Health Ministry said on Sunday it is examining a small number of cases of heart inflammation in people who had received Pfizer (NYSE:PFE)’s COVID-19 vaccine, though it has not yet drawn any conclusions. Pfizer said it has not observed a higher rate...

Read More